Deputies who are part of the Health Commission of the Legislative Assembly of Paraná (Alep) approved, this Tuesday (09), a favorable opinion on Bill 962/2019, which ensures access to medicines and products based on cannabidiol (CBD) and tetrahydrocannabinol (THC). Authored by deputy Goura (PDT), the project is now ready to be voted on in plenary.
“The approval of this project is very important because it will benefit thousands of families who will be able to use cannabidiol and tetrahydrocannabinol-based medicines to treat diseases, syndromes and disorders that are only effective in medicinal cannabis,” commented Goura.
:: Experts in Brazil are optimistic about the advance of the medical cannabis law in Argentina ::
The deputy also highlighted that the PL has a humanitarian fund, which aims to benefit people and reduce the suffering of patients and families. “The approval of the PL and now its submission for a vote in the plenary is a victory against taboos and prejudices about the medicinal use of cannabis,” he said.
The rapporteur, Deputy Michele Caputo (PSDB), criticized those who oppose the use of cannabis, better known as marijuana, in the treatment of diseases. “People don’t need to live with pain just because of the prejudice of others,” he said.
:: Medicine in Debate: A chat about medical cannabis ::
In the opinion, deputy Caputo concluded the vote for the approval of PL 962/2019 as follows: “Also considering that the bill is supported by world scientific studies and follows the trend of regulation of therapies based on cannabis, I opine for approval of the present bill.”
Source: BoF Paraná
Edition: Lia Bianchini